Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Other Non Operating Income (2016 - 2025)

Cytosorbents' Other Non Operating Income history spans 15 years, with the latest figure at $193000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at $193000.0 for Q4 2025, up 103.93% from a year ago — trailing twelve months through Dec 2025 was $9.3 million (up 320.63% YoY), and the annual figure for FY2025 was $9.3 million, up 320.62%.
  • Other Non Operating Income for Q4 2025 was $193000.0 at Cytosorbents, up from -$64000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $6.2 million in Q2 2025 to a low of -$4.9 million in Q4 2024.
  • The 5-year median for Other Non Operating Income is -$278744.0 (2021), against an average of $100952.8.
  • The sharpest move saw Other Non Operating Income plummeted 1177.6% in 2022, then skyrocketed 1235.66% in 2025.
  • Year by year, Other Non Operating Income stood at -$493488.0 in 2021, then surged by 1015.53% to $4.5 million in 2022, then tumbled by 40.61% to $2.7 million in 2023, then tumbled by 282.8% to -$4.9 million in 2024, then skyrocketed by 103.93% to $193000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $193000.0, -$64000.0, and $6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.